Correcting for physiological ripples improves epileptic focus identification and outcome prediction.

biomarker epilepsy surgery high-frequency oscillations interictal normative values

Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
02 2022
Historique:
revised: 30 11 2021
received: 08 07 2021
accepted: 30 11 2021
pubmed: 18 12 2021
medline: 21 4 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

The integration of high-frequency oscillations (HFOs; ripples [80-250 Hz], fast ripples [250-500 Hz]) in epilepsy evaluation is hampered by physiological HFOs, which cannot be reliably differentiated from pathological HFOs. We evaluated whether defining abnormal HFO rates by statistical comparison to region-specific physiological HFO rates observed in the healthy brain improves identification of the epileptic focus and surgical outcome prediction. We detected HFOs in 151 consecutive patients who underwent stereo-electroencephalography and subsequent resective epilepsy surgery at two tertiary epilepsy centers. We compared how HFOs identified the resection cavity and predicted seizure-free outcome using two thresholds from the literature (HFO rate > 1/min; 50% of the total number of a patient's HFOs) and three thresholds based on normative rates from the Montreal Neurological Institute Open iEEG Atlas (https://mni-open-ieegatlas. mcgill.ca/): global Atlas threshold, regional Atlas threshold, and regional + 10% threshold after regional Atlas correction. Using ripples, the regional + 10% threshold performed best for focus identification (77.3% accuracy, 27% sensitivity, 97.1% specificity, 80.6% positive predictive value [PPV], 78.2% negative predictive value [NPV]) and outcome prediction (69.5% accuracy, 58.6% sensitivity, 76.3% specificity, 60.7% PPV, 74.7% NPV). This was an improvement for focus identification (+1.1% accuracy, +17.0% PPV; p < .001) and outcome prediction (+12.0% sensitivity, +1.0% PPV; p = .05) compared to the 50% threshold. The improvement was particularly marked for foci in cortex, where physiological ripples are frequent (outcome: +35.3% sensitivity, +5.3% PPV; p = .014). In these cases, the regional + 10% threshold outperformed fast ripple rate > 1/min (+3.6% accuracy, +26.5% sensitivity, +21.6% PPV; p < .001) and seizure onset zone (+13.5% accuracy, +29.4% sensitivity, +17.0% PPV; p < .05-.01) for outcome prediction. Normalization did not improve the performance of fast ripples. Defining abnormal HFO rates by statistical comparison to rates in healthy tissue overcomes an important weakness in the clinical use of ripples. It improves focus identification and outcome prediction compared to standard HFO measures, increasing their clinical applicability.

Identifiants

pubmed: 34919741
doi: 10.1111/epi.17145
pmc: PMC9300035
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-496

Subventions

Organisme : CIHR
ID : FDN-143208
Pays : Canada

Informations de copyright

© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Front Neurol. 2019 Feb 12;10:94
pubmed: 30804887
Ann Neurol. 2017 May;81(5):664-676
pubmed: 28380659
JAMA Neurol. 2019 Sep 01;76(9):1070-1078
pubmed: 31180505
Epilepsia. 2013 Feb;54(2):370-6
pubmed: 23106394
Clin Neurophysiol. 2009 Aug;120(8):1457-64
pubmed: 19576848
Ann Neurol. 2017 Aug;82(2):299-310
pubmed: 28779553
Epilepsia. 2016 Jun;57(6):869-78
pubmed: 27184021
Ann Neurol. 2018 Jan;83(1):84-97
pubmed: 29244226
Ann Neurol. 2010 Feb;67(2):209-20
pubmed: 20225281
Epilepsia. 2019 Dec;60(12):2404-2415
pubmed: 31705527
Epilepsia. 2014 Nov;55(11):1872-83
pubmed: 25266626
Epilepsia. 2011 Oct;52(10):1792-801
pubmed: 21762451
Epilepsia. 2014 Oct;55(10):1602-10
pubmed: 25196064
Neuroimage Clin. 2017 Feb 24;14:566-573
pubmed: 28337411
Epilepsia Open. 2018 Sep 17;3(Suppl Suppl 2):120-126
pubmed: 30564770
Clin Neurophysiol. 2017 Jun;128(6):945-951
pubmed: 28412559
Epilepsia. 2014 Dec;55(12):1986-95
pubmed: 25470216
Epilepsia. 2018 Mar;59(3):544-554
pubmed: 29315516
J Neurosci Methods. 2018 Jun 1;303:7-15
pubmed: 29605667
J Neurophysiol. 2013 Oct;110(8):1958-64
pubmed: 23926038
Sci Transl Med. 2019 Oct 16;11(514):
pubmed: 31619544
Clin Neurophysiol. 2015 Nov;126(11):2049-57
pubmed: 25746721
Brain Commun. 2021 Mar 14;3(2):fcab042
pubmed: 33959709
Epilepsia. 2015 Feb;56(2):197-206
pubmed: 25556401
Clin Neurophysiol. 2016 Apr;127(4):2140-8
pubmed: 26838666
Epilepsia. 1997 Dec;38(12):1300-14
pubmed: 9578526
Epilepsia. 2009 Apr;50(4):617-28
pubmed: 18801037
Epilepsia. 2022 Feb;63(2):483-496
pubmed: 34919741
Curr Opin Neurobiol. 2011 Jun;21(3):452-9
pubmed: 21371881
Ann Neurol. 2004 Jul;56(1):108-15
pubmed: 15236407
Ann Neurol. 2018 Sep;84(3):374-385
pubmed: 30051505
Ann Neurol. 2020 Feb;87(2):289-301
pubmed: 31777112
Ann Clin Transl Neurol. 2018 Aug 09;5(9):1062-1076
pubmed: 30250863
Clin Neurophysiol. 2017 Jul;128(7):1220-1226
pubmed: 28521270
Clin Neurophysiol. 2015 Aug;126(8):1505-13
pubmed: 25499074
Clin Neurophysiol. 2018 Oct;129(10):2089-2098
pubmed: 30077870
Brain. 2018 Apr 1;141(4):1130-1144
pubmed: 29506200
Neurology. 2015 Jul 14;85(2):120-8
pubmed: 26070338
Epilepsia. 2017 Aug;58(8):1316-1329
pubmed: 28666056
Neurology. 2018 Sep 11;91(11):e1040-e1052
pubmed: 30120133
Hum Brain Mapp. 2012 Mar;33(3):569-83
pubmed: 21432945
Nat Commun. 2018 Jun 1;9(1):2155
pubmed: 29858570
Sci Rep. 2017 Oct 23;7(1):13836
pubmed: 29062105
Epilepsia. 2013 May;54(5):848-57
pubmed: 23294353
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:2543-2546
pubmed: 31946415
Clin Neurophysiol. 2018 Jun;129(6):1311-1319
pubmed: 29523391
Clin Neurophysiol. 2012 Apr;123(4):670-80
pubmed: 21940200
Neurology. 2020 Oct 20;95(16):e2235-e2245
pubmed: 32753439
Clin Neurophysiol. 2014 Jul;125(7):1339-45
pubmed: 24368032

Auteurs

Willemiek J E M Zweiphenning (WJEM)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.
University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Nicolás von Ellenrieder (N)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

François Dubeau (F)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Laurence Martineau (L)

Department of Neurology, Grenoble-Alpes University Hospital and Grenoble-Alpes University, Grenoble, France.

Lorella Minotti (L)

Department of Neurology, Grenoble-Alpes University Hospital and Grenoble-Alpes University, Grenoble, France.

Jeffery A Hall (JA)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Stephan Chabardes (S)

Department of Neurosurgery, Grenoble-Alpes University Hospital and Grenoble-Alpes University, Grenoble, France.

Roy Dudley (R)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Philippe Kahane (P)

Department of Neurology, Grenoble-Alpes University Hospital and Grenoble-Alpes University, Grenoble, France.

Jean Gotman (J)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Birgit Frauscher (B)

Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH